Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 102684

In scope icon M 10 E
QID 102684 (Type "102684" in App Search)
A 64-year-old woman presents to her primary care physician with complaints of fatigue, a sore mouth, as well as occasional abdominal pain and diarrhea for the past several months. She denies any loss of balance, trouble walking, numbness, pain, or tingling in her hands or feet. She has a past medical history of morbid obesity, depression, rheumatoid arthritis, suicide, anxiety, hypertension, diabetes, and factor V Leiden being managed by her PCP. Her temperature is 99.4°F (37.4°C), blood pressure is 154/94 mmHg, pulse is 87/min, respirations are 18/min, and oxygen saturation is 98% on room air. Physical examination is significant for the finding in Figure A. The patient's creatinine is 2.0 mg/dL at this visit. Which of the following is most likely to be found in this patient?
  • A

Aplastic anemia

4%

1/23

Hemolytic anemia

4%

1/23

Megaloblastic anemia

9%

2/23

Microcytic anemia

9%

2/23

Polycythemia

70%

16/23

  • A

Select Answer to see Preferred Response

bookmode logo Review TC In New Tab

This patient is suffering from fatigue and mucositis in the setting of a history of rheumatoid arthritis suggesting she is suffering from toxicity from methotrexate use. A megaloblastic anemia is common with methotrexate use.

Folic acid deficiency leads to decreased DNA synthesis resulting in a megaloblastic anemia. Folic acid deficiency differs from vitamin B12 deficiency in 2 ways:

1) Neurologic symptoms (demyelination and subacute combined degeneration of the spinal cord) are seen with vitamin B12 deficiency but not with pure folate deficiency.

2) Folic acid deficiency is associated with a normal serum methylmalonic acid (MMA) and increased homocysteine; whereas, vitamin B12 deficiency leads to increases in both MMA and homocysteine.

Methotrexate is commonly used as a disease-modifying agent in rheumatoid arthritis. As a dihydrofolate reductase inhibitor, it can cause a folate deficiency and a megaloblastic anemia. Other findings suggestive of methotrexate toxicity include mucositis and stomatitis.

Figure A is a clinical image of glossitis/mucositis which can be seen as a toxicity of methotrexate.

Incorrect Answers:
Answer 1: Aplastic anemia is a possible complication of parvovirus B19 infection or with methotrexate use. It is a less common complication when compared to a megaloblastic anemia given the mechanism of methotrexate.

Answer 2: Hemolytic anemia would present with jaundice, elevated LDH, and a low haptoglobin and can occur secondary to infections and certain drugs. It is a less likely diagnosis in this patient given her history of rheumatoid arthritis and absence of symptoms.

Answer 4: Microcytic anemia would present with a decreased MCV and could occur secondary to iron deficiency or GI bleeding. A megaloblastic anemia is more common with methotrexate use.

Answer 5: Polycythemia vera is a condition of increased cell counts of all 3 cell lines (platelets, white blood cells, and red blood cells). It would not be seen with methotrexate use.

Bullet Summary:
Megaloblastic anemia and mucositis are common complications seen with methotrexate use.

Authors
Rating
Please Rate Question Quality

3.5

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

(11)

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options